EPAM Systems Surpasses Global Software Development Benchmarks

EPAM Systems, Inc.

NEWTOWN, PAEPAM Systems, Inc. (NYSE: EPAM) has announced a notable achievement in software development, outperforming global quality and productivity standards established by BlueOptima. This accomplishment underscores EPAM’s commitment to excellence in the competitive field of IT outsourcing.

According to BlueOptima’s Q2 2024 Global Benchmark Report, over 76.5% of EPAM’s lead developers exceeded the global average, showcasing their superior engineering talent across various industries and regions. The report, which evaluates more than 700,000 developers from 30 countries, provides data-driven insights crucial for strategic decision-making and optimizing software development lifecycles.

Balazs Fejes, EPAM’s President of Global Business and Chief Revenue Officer, highlighted the importance of this achievement, stating, “We’re delighted that our global development teams have surpassed the independent quality and productivity benchmarks set by BlueOptima. In today’s cost-conscious environment, this achievement reflects our commitment to delivering exceptional and differentiating value across our global teams.”

Jason Rolles, CEO and Managing Director of BlueOptima, remarked on the evaluation’s significance, “Our evaluation of EPAM’s lead developers against our extensive global dataset highlights their exceptional quality and productivity. By leveraging our Developer Analytics platform, organizations can make informed decisions and optimize their software development processes.”

For enterprise IT outsourcing clients, this performance benchmark is vital. It serves as a standard for assessing global software development productivity and quality, helping clients optimize their outsourced projects by ensuring they partner with the most effective development teams.

EPAM’s success in surpassing these global benchmarks not only enhances its reputation but also provides its clients with confidence in the company’s ability to deliver high-quality, efficient software development solutions.

READ:  Windtree Therapeutics Files Patent for Istaroxime Derivatives to Combat Acute Myocardial Arrhythmia

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.